The Community Pharmacy Practice Research Fellowship is a 2- to 3-year training program
with particular emphases on community pharmacy practice-based research and prescription
drug abuse prevention and treatment. The program fosters practice-related research
skills through multiple avenues, including: completion of coursework across ETSU's
Academic Health Sciences Center colleges; participation in interprofessional, externally
funded, practice-based prescription drug abuse research projects; advancement of patient
care skills through community pharmacy and ambulatory care practice experiences; and
development of teaching skills through active participation in the Gatton College
of Pharmacy professional curriculum. The Fellow has the opportunity to complete a
public health certificate program or MPH degree through the College of Public Health,
and a Teaching and Learning Certificate through the College of Pharmacy.
The overall aims of the Community Pharmacy Practice Research Fellowship Program in
the Gatton College of Pharmacy at ETSU are:
To provide an analytic, integrative, and authentic practice-focused training program
of such scope and quality that trainees will develop the background, confidence, and
capacity to undertake creative and independent practice-based research
To equip pharmacists with a breadth of knowledge and skills to enable them to function
in a teaching capacity in social and behavioral pharmaceutical sciences disciplines
To develop the ability to evaluate research endeavors critically and to communicate
scientific thought effectively in verbal and written form
To advance practice-related knowledge, with particular emphasis placed on prescription
drug abuse prevention and treatment
To develop projects and new approaches which demonstrate and evaluate health care
effectiveness and systems effectiveness in providing pharmacy services as an integral
component of overall patient care
Aaron Salwan, of Stow, Ohio, has been accepted into the Community Pharmacy Practice Research Fellowship Program.
He graduated from Ohio Northern University Raabe College of Pharmacy in May of 2017.
"My desire to fight the prescription drug and opioid epidemic brought me to Gatton,"
said Salwan. "I have worked to find community pharmacy interventions to help those
with substance use disorders."
Dr. Salwan is an adjunct faculty member at East Tennessee State University. He has
worked in a community setting, CVS Pharmacy, for seven years and is a member of the
Summit County Opiate Taskforce in Akron, Ohio. Dr. Salwan has worked closely with
the Alcohol, Drug Addiction and Mental Health (ADM) Board in his community with a
focus on disposing prescription medications properly to help fight addiction. As a
resident, Dr. Salwan will work with patients struggling with mental health issues
and substance abuse and observe behaviors that will present opportunities for pharmacist
intervention. Aaron will pursue a Master of Public Health in Community and Behavioral
Health. Dr. Salwan’s career interests include behavioral health, substance abuse disorder
and applying pharmaceutical knowledge to public health problems.
Tyler Melton, of Sylva, North Carolina, started the Fellowship Program in July 2018. He received his bachelor’s in chemistry
and biology from Western Carolina University in 2008, and he earned his PharmD from
ETSU in 2012. Upon graduation he practiced as a staff pharmacist at Angel Medical
Center, a Top 100 Critical Access Hospital located in Franklin, North Carolina. Later
he transitioned to a position as a Walmart Pharmacy Manager in his hometown of Sylva.
Most recently he worked for the Cherokee Indian Hospital Authority, located on the
Qualla boundary in North Carolina. He has over 12 years of community pharmacy experience.
“My experiences as a student at the Gatton College of Pharmacy were formative and
exciting,” Melton said. “The college supported, encouraged and provided me with diverse
personal and professional opportunities that shaped me as a healthcare professional
and prepared me to effectively practice pharmacy in the mountains of North Carolina.”
Those experiences led him to apply for the fellowship, along with the accomplishments
of the fellowship director and Gatton faculty member Dr. Nick Hagemeier, who is nationally
recognized for his research into prescription drug abuse prevention and treatment.
Ultimately, Melton would like to pursue a career in pharmacy academia and prescription
drug abuse research.
KariLynn Dowling, PharmD, MPH, BCACP, completed the Fellowship Program in June 2018.
Dr. Dowling is a 2014 graduate of the University of Montana Skaggs School of Pharmacy.
She completed residency training at Penobscot Community Health Care in Bangor, Maine,
as a member of the 2014-15 PGY1 Community Pharmacy and 2015-16 PGY2 Health-Systems Pharmacy Administration residency
classes. As a resident, Dr. Dowling focused on controlled substance stewardship and
program implementation for intranasal naloxone and medication-assisted therapy initiatives. During
the Fellowship Program, Dr. Dowling primarily focused her research and professional
development activities on harm reduction strategies, including significant involvement
on the ETSU Research Development Committee grant, “Community Pharmacist Engagement in Hepatitis C and HIV Prevention: A Feasibility Study” (PI: Dr. Nick Hagemeier). She earned her Master of Public Health degree with a
concentration in Community and Behavioral Health in May 2018. Her career interests
include drug abuse research, opioid use disorder treatment, and academia. After completing
the Fellowship Program, Dr. Dowling took a position as an Assistant Professor of Pharmacy
Practice at the Gatton College of Pharmacy.
Daniel Ventricelli, PharmD, graduated from the University of Connecticut School of
Pharmacy in May 2013 and completed a Community Pharmacy PGY-1 Residency with the West
Virginia University School of Pharmacy and Kroger in June 2014. As a community pharmacy
resident, Dr. Ventricelli's focus was on medication therapy management, clinical program
development, and teaching at the West Virginia University School of Pharmacy, where
he held an adjunct faculty appointment. Dr. Ventricelli was also a member of the clinical
treatment team on the Dual Diagnostic Unit at the Chestnut Ridge Center for Mental
Health Services in Morgantown, West Virginia. While working on the Dual Diagnostic
Unit he played an integral role in the treatment of patients struggling with substance
use disorders. His practice interests include addiction services, diabetes care and
medication therapy management. Dr. Ventricelli’s research at ETSU focused on prescription
drug abuse and misuse communication among prescribers and pharmacists. Dan earned
an MPH degree in Community and Behavioral health and completed the fellowship in June
2016. He is currently an Assistant Professor at the University of the Sciences, Philadelphia
College of Pharmacy.
Dr. Sevak earned a bachelors in pharmacy and masters in pharmacology in India. During
the masters program, Dr. Sevak developed a strong interest in the impact of drugs
on brain and behavior, and joined the Ph.D. program in pharmacology at the University
of Texas Health Science Center at San Antonio. During graduate school, Dr. Sevak received
rigorous training on the principles of pharmacology and behavioral analysis in the
context of drug abuse. Dr. Sevak earned his Ph.D. in 2006 and completed postdoctoral
research training on the abuse of prescription stimulants and methamphetamine at the
University of Kentucky in 2009. Dr. Sevak has published several articles in reputable
peer-reviewed journals including, the Journal of Clinical Psychopharmacology and the
Journal of Pharmacology and Experimental Therapeutics, and he has presented research
at numerous scientific conferences. He has received several awards, including the
Graduate Student of the Year from the University of Texas, Young Scientist Award from
the American Society for Pharmacology and Experimental Therapeutics, and the Early
Career Investigator award from the College on Problems of Drug Dependence. Dr. Sevak
joined the University of California, Los Angeles (UCLA) as a faculty member in 2009.
At UCLA, Dr. Sevak continued his research on abuse of stimulant medications that are
prescribed in clinics and abused on the streets and was awarded hundreds of thousands
of dollars in research funding from the National Institute on Drug Abuse and private
sources. His work at UCLA was recognized nationally in the receipt of honors and awards
from reputed organizations, such as the American College of Neuropsychopharmacology,
the Friends of the Semel Institute for Neuroscience and the National Institute on
Drug Abuse. Dr. Sevak joined the East Tennessee State University (ETSU) Gatton College
of Pharmacy as a fellow and adjunct faculty member in July 2014 and completed the
fellowship in June 2016. He earned a biostatistics certificate program during the
fellowship. Dr. Sevak is presently completing a PGY1 residency at Auburn University.
Individuals interested in fellowship opportunities are encouraged to contact Dr. Hagemeier
at email@example.com or 423-439-6239.